Published in Diabetes on February 01, 1994
Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev (2008) 2.79
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.81
Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. Am J Pathol (2009) 1.53
Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. Biochemistry (2008) 1.51
Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity. J Clin Invest (2014) 1.37
Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci U S A (1997) 1.26
Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. Am J Pathol (1995) 1.20
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes. J Clin Invest (2014) 1.17
Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol (1999) 1.06
A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6. Proc Natl Acad Sci U S A (1995) 0.95
A feline model of experimentally induced islet amyloidosis. Am J Pathol (2000) 0.84
Annexin A5 directly interacts with amyloidogenic proteins and reduces their toxicity. Biochemistry (2009) 0.81
Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption. J Biol Chem (2015) 0.77
The Effects of Lipid Membranes, Crowding and Osmolytes on the Aggregation, and Fibrillation Propensity of Human IAPP. J Diabetes Res (2015) 0.75
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res (1998) 4.39
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes (1999) 3.30
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A (1990) 3.29
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res (1996) 2.89
17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res (2000) 2.81
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53
Increased HER2 with U.S. Food and Drug Administration-approved antibody. J Clin Oncol (1999) 2.48
Absorption and circular dichroism spectroscopy of nucleic acid duplexes and triplexes. Methods Enzymol (1995) 2.08
Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab (2008) 1.95
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.81
Staining methods for identification of amyloid in tissue. Methods Enzymol (1999) 1.80
Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. J Clin Oncol (2001) 1.76
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med (1984) 1.76
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem (2001) 1.72
Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett (1989) 1.68
p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors. Am J Clin Pathol (1996) 1.67
Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn (2001) 1.67
Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol (1989) 1.60
Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol (1987) 1.60
Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes (2001) 1.54
Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol (1994) 1.50
'Amylin' hormone. Nature (1989) 1.44
Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. Gynecol Oncol (2000) 1.43
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Feline insular amyloid: association with diabetes mellitus. Vet Pathol (1981) 1.36
Tumorigenesis by Millipore filters in mice: histology and ultrastructure of tissue reactions as related to pore size. J Natl Cancer Inst (1973) 1.33
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer (2002) 1.33
The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 1.33
Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. Am J Vet Res (1981) 1.30
Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res (2000) 1.28
Molecular markers in male breast carcinoma. Cancer (1998) 1.26
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes (1998) 1.22
Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis. Am J Pathol (1995) 1.20
HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res (2000) 1.20
Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med (1994) 1.18
Light and electron microscopic studies of islet amyloid in diabetic cats. Diabetes (1973) 1.15
Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab (2000) 1.14
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia (2009) 1.13
HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol (1992) 1.11
Morphometric analysis of the "mucocellular layer" overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol (2000) 1.11
Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia (1987) 1.10
Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol (1994) 1.10
Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. Arch Pathol Lab Med (1998) 1.10
Feline insular amyloid: incidence in adult cats with no clinicopathologic evidence of overt diabetes mellitus. Vet Pathol (1981) 1.10
A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J (1998) 1.09
The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest (1998) 1.09
Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res (2002) 1.08
Spontaneous diabetes mellitus-islet amyloid complex in adult cats. Am J Pathol (1986) 1.08
Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab (1996) 1.08
Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions. Cell Death Differ (2010) 1.07
Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett (1997) 1.07
Canine urolithiasis: a review of 133 clinical and 23 necropsy cases. J Am Vet Med Assoc (1970) 1.05
Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia (2006) 1.05
Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Diabetes (1996) 1.04
Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol (1998) 1.04
Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol (1993) 1.03
Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia (1989) 1.03
Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients. Histopathology (2002) 1.01
Expression of an immediate early gene, IEX-1, in human tissues. Histochem Cell Biol (2001) 1.00
Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol (1995) 1.00
Pancreatic ganglioneuronal amyloid. Occurrence in diabetic cats with islet amyloidosis. Am J Pathol (1985) 0.99
Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Res (1975) 0.98
Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes (1990) 0.98
Ontogeny of the 1,25-dihydroxyvitamin D3 receptor in fetal rat bone. J Bone Miner Res (1996) 0.98
Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol (2002) 0.98
Foreign body tumorigenesis. CRC Crit Rev Toxicol (1976) 0.98
Systemic AA amyloidosis in captive cheetahs (Acinonyx jubatus). Vet Pathol (1997) 0.97
High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet Pathol (1985) 0.97
Purification of tryptase from a human mast cell line. J Leukoc Biol (1990) 0.97
Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diabetes Res Clin Pract (1989) 0.97
Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol (1999) 0.96
Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. J Comp Pathol (1986) 0.96
Feline insular amyloid: immunohistochemical and immunochemical evidence that the amyloid is insulin-related. Vet Pathol (1985) 0.96
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer (1994) 0.95
Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol (1996) 0.95
Immuno-localization of the calcitriol receptor, calbindin-D28k and the plasma membrane calcium pump in the human eye. Curr Eye Res (1995) 0.95
Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia (2005) 0.95
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunction. Metabolism (2000) 0.94
Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. Am J Physiol (1997) 0.94
Anastomotic leaks: what is the best diagnostic imaging study? Dis Colon Rectum (2007) 0.94
Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): an animal model of human non-insulin-dependent diabetes mellitus. Vet Pathol (1996) 0.94
hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol (2001) 0.94
Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. Biochim Biophys Acta (1983) 0.93
Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol (1989) 0.93
Naturally occurring reticuloendotheliosis in turkeys: transmission. J Natl Cancer Inst (1976) 0.92